Cost benefit analysis of sexually transmitted diseases

FEMS Immunology and Medical Microbiology

Volumn 24, Issue 4, 1999, Pages 461-467

  Bulut, Ayşen ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Cost benefit analysis; Health economic; Sexually transmitted disease

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CHLAMYDIASIS; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DEVELOPING COUNTRY; GONORRHEA; HEALTH CARE COST; HUMAN; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE; SYPHILIS;

COST-BENEFIT ANALYSIS; HUMANS; SEXUALLY TRANSMITTED DISEASES;

EID: 0032967075     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(99)00064-4     Document Type: Article

References (20)

1. Dallabetta, G.A., Field, M.L., Laga, M., Islam, Q.M. (1997) STDs: Global burden and challenges for control. In: Control of Sexually Transmitted Diseases, a Handbook for the Design and Management of Programs. (Dallabetta, G.A., Laga, M., Lamptey, P.R., Eds.), pp. 1-21. AIDSCAP and Family Health International, Arlington, USA.
2. Lande, R. (1993) Controlling Sexually Transmitted Diseases, Population Reports, Series L., No. 9., p. 19. Johns Hopkins School of Public Health, Population Information Program, Baltimore, MD, USA.
3. Over, M., Piot, P. (1993) HIV infection and sexually transmitted diseases. In: Disease Control Priorities in Developing Countries (Jamison, D.T., Mosley, W.H., Measham, A.R., Babadilla, J.L., Eds.) pp. 445-529. Oxford University Press, New York, USA.
4. Washington A.E., Arno P.S., Brooks M.A. The economic cost of PID? JAMA. 255:1986;17-35.
5. Beaglehole, R., Bonita, R., Kjellstrom, T. (1993) Basic Epidemiology, pp. 133-142. World Health Organization, Geneva, Switzerland.
6. Drummond, M., Smith, G.T., Wells, N. (1988) Introduction to economic evaluation methods. In: Economic Evaluation in the Development of Medicines. pp. 9-14, Office of Health Economics, London, UK.
7. Wakfield, D.S. (1993) Understanding the costs of nosocomial infections. In: Prevention and Control of Nosocomial Infections (Wenzel, R.P., Ed.), pp. 21-41, Willams and Wilkins, MD, USA.
8. Cilingiroglu, N. (1995) Saglik Ekonomisi. In: Halk Sagligi Temel Bilgiler (Bertan, M., Guler, C., Eds.) (Health Economics. In: Public Health Essentials), pp. 411-412. Gunes Kitabevi, Ankara, Turkey.
9. La Ruche G., Lorougnon F., Digbeu N. Therapeutic algorithms for the management of sexually transmitted diseases at the peripheral level in Cote d'Ivory: assessment of efficacy and cost. Bull. WHOo. 73:(3):1995;305-313.
10. Adler M.W. Sexually transmitted diseases control in developing countries. Genitourin. Med. 72:(2):1996;83-88.
11. Davies H.D., Wang E.E. Periodic health examination 1996 update: 2. Screening for chlamydial infections. Canadian Task Force on the Periodic Health Examination. Can. Med. Assoc. J. 154:(11):1996;1631-1644.
12. McFarland W., Kahn J.G., Katzenstein D.A., Mvere D., Shamu R. Deferral of blood donors with risk factors for HIV infection saves lives and money in Zimbabwe. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 9:(22):1995;183-192.
13. Friedland L.R., Kulick R.M., Biro F.M., Patterson A. Cost-effectiveness decision analysis of intramuscular ceftriaxone versus oral cefixime in adolescents with gonococcal cervicitis. Ann. Emerg. Med. 27:(3):1996;299-304.
14. Moses S., Manji F., Bradley J.E., Nagelkerke N.J.D., Malisa M.A., Plummer F.A. Impact of user fees on attendance at a referral centre for sexually transmitted diseases in Kenya. Lancet. 340:(8817):1992;463-466.
15. Washington A.E., Johnson R.E., Sanders L.L. Chlamydia trachomatis infections in US: What are they costing us? JAMA. 257:1987;2070.
16. Winikoff B. Women's Health: An Alternative Perspective for Choosing Interventions. Stud. Fam. Plan. 19:1988;197-214.
17. Duke C.D., Speidel J.J. Women's Reproductive health. JAMA. 266:1991;1846-1847.
18. The World Development Report (1993) IBRD, Oxford University Press, New York, USA.
19. Tiefer, L. (1995) Sex Is Not a Natural Act and Other Essays, Westview Press, Oxford.
20. Sng, E.H. (1990) Necessary laboratory support at the peripheral, regional, and national levels in developing countries. In: Sexually Transmitted Disease (Holmes, K., Mardh, P.A., Sparling, P.F., Wiesner, M.D., et al., Eds.), pp. 985-990. McGraw Hill, New York, USA.